Project Details
Short title | A randomised, open-label, multicentre, Phase III trial of in vivo purging with anti-CD38 (Daratumumab) to enhance myeloma autografting (IPANEMA) |
---|---|
Status | Finished |
Effective start/end date | 1/10/20 → 31/12/23 |
Funding
- JANSSEN PHARMACEUTICA NV